Hologic (HOLX) Tops Q1 EPS by 3c; Bumps Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Hologic (HOLX) PT Raised to $33 at Needham & Company on Strong Q1 Growth Acceleration
January 29, 2015 8:24 AM ESTNeedham & Company analyst Mike Matson reiterated a Buy rating and boosted his price target on Hologic (NASDAQ: HOLX) to $33.00 (from $30.00) following broad-based growth acceleration in Q1.
Matson commented, "HOLX's F1Q15 revenue was consistent with its 1/12/15 preannouncement while EPS beat consensus. Management raised... More
